These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 32948440)

  • 1. Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
    Rana AK; Rahmatkar SN; Kumar A; Singh D
    Cytokine Growth Factor Rev; 2021 Apr; 58():92-101. PubMed ID: 32948440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition.
    Liu X; Verma A; Garcia G; Ramage H; Lucas A; Myers RL; Michaelson JJ; Coryell W; Kumar A; Charney AW; Kazanietz MG; Rader DJ; Ritchie MD; Berrettini WH; Schultz DC; Cherry S; Damoiseaux R; Arumugaswami V; Klein PS
    Proc Natl Acad Sci U S A; 2021 Oct; 118(42):. PubMed ID: 34593624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition.
    Liu X; Verma A; Garcia G; Ramage H; Myers RL; Lucas A; Michaelson JJ; Coryell W; Kumar A; Charney AW; Kazanietz MG; Rader DJ; Ritchie MD; Berrettini WH; Schultz DC; Cherry S; Damoiseaux R; Arumugaswami V; Klein PS
    medRxiv; 2021 Jul; ():. PubMed ID: 33655282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen Synthase Kinase-3 Interaction Domain Enhances Phosphorylation of SARS-CoV-2 Nucleocapsid Protein.
    Yun JS; Song H; Kim NH; Cha SY; Hwang KH; Lee JE; Jeong CH; Song SH; Kim S; Cho ES; Kim HS; Yook JI
    Mol Cells; 2022 Dec; 45(12):911-922. PubMed ID: 36572560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
    Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
    FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: Opportunities, challenges and future directions for cerebral stroke management.
    Rana AK; Singh D
    Neuropharmacology; 2018 Sep; 139():124-136. PubMed ID: 30017999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.
    Rudd CE
    Front Immunol; 2020; 11():1638. PubMed ID: 32695123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.
    Vlachakis D; Papakonstantinou E; Mitsis T; Pierouli K; Diakou I; Chrousos G; Bacopoulou F
    Food Chem Toxicol; 2020 Dec; 146():111805. PubMed ID: 33038452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.
    Fakhri S; Nouri Z; Moradi SZ; Akkol EK; Piri S; Sobarzo-Sánchez E; Farzaei MH; Echeverría J
    Molecules; 2021 May; 26(10):. PubMed ID: 34068970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication.
    Wu CH; Yeh SH; Tsay YG; Shieh YH; Kao CL; Chen YS; Wang SH; Kuo TJ; Chen DS; Chen PJ
    J Biol Chem; 2009 Feb; 284(8):5229-39. PubMed ID: 19106108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
    Keam S; Megawati D; Patel SK; Tiwari R; Dhama K; Harapan H
    Rev Med Virol; 2020 Sep; 30(5):e2123. PubMed ID: 32648313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3β-N-nsp3 cascade.
    Lin YY; Yao R; Zhuang J; Wang B; Du L; Guo D; Pan JA; Peng X
    J Med Virol; 2023 Jun; 95(6):e28832. PubMed ID: 37264691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
    Schreiber A; Viemann D; Schöning J; Schloer S; Mecate Zambrano A; Brunotte L; Faist A; Schöfbänker M; Hrincius E; Hoffmann H; Hoffmann M; Pöhlmann S; Rescher U; Planz O; Ludwig S
    Cell Mol Life Sci; 2022 Jan; 79(1):65. PubMed ID: 35013790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis.
    Jafari A; Esmaeilzadeh Z; Khezri MR; Ghasemnejad-Berenji H; Pashapour S; Sadeghpour S; Ghasemnejad-Berenji M
    J Food Biochem; 2022 Oct; 46(10):e14345. PubMed ID: 35866873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating Oxidative Stress and Inflammation in COVID-19 by Molecular Hydrogen Therapy: Mechanisms and Perspectives.
    Alwazeer D; Liu FF; Wu XY; LeBaron TW
    Oxid Med Cell Longev; 2021; 2021():5513868. PubMed ID: 34646423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.
    Delgado-Roche L; Mesta F
    Arch Med Res; 2020 Jul; 51(5):384-387. PubMed ID: 32402576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niclosamide for Covid-19: bridging the gap.
    Al-Kuraishy HM; Al-Gareeb AI; Alzahrani KJ; Alexiou A; Batiha GE
    Mol Biol Rep; 2021 Dec; 48(12):8195-8202. PubMed ID: 34664162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ingavirin might be a promising agent to combat Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2).
    Malík I; Kovac G; Padrtova T; Hudecova L
    Ceska Slov Farm; 2020; 69(3):107-111. PubMed ID: 32972153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.